Latest period
$718M
YoY change
-1.3%
5Y CAGR
+4.0%
Peak year (FY2022)
$685M
Latest annual
$664M
Stock-Based Compensation history chart for Abbott Laboratories (ABT) from 2016 to 2025
Latest: $664M
Stock-Based Compensation growth chart for Abbott Laboratories (ABT) from 2016 to 2025
Latest: -1.3%
Stock-Based Compensation history table for Abbott Laboratories (ABT) from 1989 to 2025
| FY2025 | $664M | -1.3% | -$9M | ||
| FY2024 | $673M | +4.5% | +$29M | ||
| FY2023 | $644M | -6.0% | -$41M | ||
| FY2022 | $685M | +7.0% | +$45M | ||
| FY2021 | $640M | +17.2% | +$94M | ||
| FY2020 | $546M | +5.2% | +$27M | ||
| FY2019 | $519M | +8.8% | +$42M | ||
| FY2018 | $477M | +17.5% | +$71M | ||
| FY2017 | $406M | +31.0% | +$96M | ||
| FY2016 | $310M | +6.2% | +$18M | ||
| FY2015 | $292M | +18.7% | +$46M | ||
| FY2014 | $246M | -6.1% | -$16M | ||
| FY2013 | $262M | -39.5% | -$171M | ||
| FY2012 | $433M | +13.1% | +$50M | ||
| FY2011 | $383M | -1.1% | -$4.18M | ||
| FY2010 | $387M | +5.7% | +$20.8M | ||
| FY2009 | $366M | +5.6% | +$19.3M | ||
| FY2008 | $347M | +649.0% | +$301M | ||
| FY2007 | $46.3M | -66.1% | -$90.1M | ||
| FY2006 | $136M | +1300.5% | +$127M | ||
| FY2005 | $9.75M | -4.6% | -$475K | ||
| FY2004 | $10.2M | +33.5% | +$2.56M | ||
| FY2003 | $7.66M | -34.7% | -$4.06M | ||
| FY2002 | $11.7M | — | +$11.7M | ||
| FY2001 | $0.00 | — | $0.00 | ||
| FY2000 | $0.00 | — | $0.00 | ||
| FY1999 | $0.00 | — | $0.00 | ||
| FY1998 | $0.00 | — | $0.00 | ||
| FY1997 | $0.00 | — | $0.00 | ||
| FY1996 | $0.00 | — | $0.00 | ||
| FY1995 | $0.00 | — | $0.00 | ||
| FY1994 | $0.00 | — | $0.00 | ||
| FY1993 | $0.00 | — | $0.00 | ||
| FY1992 | $0.00 | — | $0.00 | ||
| FY1991 | $0.00 | — | $0.00 | ||
| FY1990 | $0.00 | — | $0.00 | ||
| FY1989 | $0.00 | — | — |
- FY2025$664M-1.3%
- FY2024$673M+4.5%
- FY2023$644M-6.0%
- FY2022$685M+7.0%
- FY2021$640M+17.2%
- FY2020$546M+5.2%
- FY2019$519M+8.8%
- FY2018$477M+17.5%
- FY2017$406M+31.0%
- FY2016$310M+6.2%
- FY2015$292M+18.7%
- FY2014$246M-6.1%
- FY2013$262M-39.5%
- FY2012$433M+13.1%
- FY2011$383M-1.1%
- FY2010$387M+5.7%
- FY2009$366M+5.6%
- FY2008$347M+649.0%
- FY2007$46.3M-66.1%
- FY2006$136M+1300.5%
- FY2005$9.75M-4.6%
- FY2004$10.2M+33.5%
- FY2003$7.66M-34.7%
- FY2002$11.7M—
- FY2001$0.00—
- FY2000$0.00—
- FY1999$0.00—
- FY1998$0.00—
- FY1997$0.00—
- FY1996$0.00—
- FY1995$0.00—
- FY1994$0.00—
- FY1993$0.00—
- FY1992$0.00—
- FY1991$0.00—
- FY1990$0.00—
- FY1989$0.00—
Stock-Based Compensation values are taken from Abbott Laboratories's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Abbott Laboratories (ABT)
Stock-Based Compensation for Abbott Laboratories (ABT): headline value $718M · YoY -1.3%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Abbott Laboratories (ABT) stock-based compensation totalled $664M – edged down 1.3% year-over-year.
Through 2020–2025 (5 years), Abbott Laboratories stock-based compensation delivered a +4.0% annualised rate; with mixed annual results across the window.
2022 marks the peak stock-based compensation at $685M, with the historical low of $0.00 recorded in 1989.
Abbott Laboratories Stock-Based Compensation by Year
Abbott Laboratories Stock-Based Compensation 2025: $664M
In 2025, Abbott Laboratories reported stock-based compensation of $664M, edged down 1.3% below 2024.
Abbott Laboratories Stock-Based Compensation 2024: $673M
Abbott Laboratories stock-based compensation in 2024 was $673M, edged up 4.5% from 2023.
Abbott Laboratories Stock-Based Compensation 2023: $644M
2023's stock-based compensation for Abbott Laboratories came in at $644M, declined 6.0% below 2022.
Abbott Laboratories Stock-Based Compensation 2022: $685M
Abbott Laboratories posted stock-based compensation of $685M in 2022, grew 7.0% from 2021. This figure represents the highest annual value in the available history.
Abbott Laboratories Stock-Based Compensation 2021: $640M
Abbott Laboratories stock-based compensation in 2021 was $640M.
See more financial history for Abbott Laboratories (ABT).
Sector peers by Stock-Based Compensation
Healthcare peers of Abbott Laboratories (ABT), ranked by their latest stock-based compensation
| $1.35B | |
| $971M | |
| $955M | |
| $626M | |
| $494M | |
| $310M | |
| $0.00 | |
| $0.00 |
- $1.35B
- $955M
- $626M
- $494M
- $0.00
- $0.00
Frequently asked questions
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.16% TTM
- Dividend Profile2.30% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History9 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.